{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:32:52Z","timestamp":1787776372737,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Cytol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Platinum resistance in cancer cells plays an important role in the recurrence and progression of high-grade serous carcinoma (HGSC). Advanced or recurrent HGSC often presents with substantial ascites fluid retention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To demonstrate that ascites fluid sampling could help evaluate the predictive markers for platinum resistance or sensitivity in peritoneal lesions of HGSC, we compared the expression of platinum response markers of cancer cells in ascites fluid with that in peritoneal lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Thirty samples from 10 HGSC patients were collected, including formalin-fixed paraffin-embedded specimens obtained from peritoneal lesions and primary ovarian lesions, and cell block specimens obtained from ascites fluid. The morphology of the cancer cells was evaluated by hematoxylin and eosin staining. The expression of predictive markers for platinum response in cancer cells was evaluated by immunohistochemistry for excision repair cross-complementation group 1 (ERCC1) and Schlafen 11 (SLFN11).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The morphology of cancer cells in cell blocks (CBs) was similar to that in peritoneal and primary lesions. The expression of ERCC1 and SLFN11 in cancer cells in CBs was positively correlated with that in peritoneal lesions. These results indicated that CBs of ascites fluid would be useful for evaluating the expression of predictive markers for platinum resistance and sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrated that HGSC cells in ascites fluid may reflect the expression of predictive markers for platinum resistance or sensitivity in cancer cells in peritoneal metastatic lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joc.joc_152_24","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:00:09Z","timestamp":1748527209000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Platinum Resistance or Sensitivity Markers by Analysis of Cell Block Specimens of Ascites Fluid in High-Grade Serous Carcinoma"],"prefix":"10.4103","volume":"42","author":[{"given":"Rinako","family":"Ogawa","sequence":"first","affiliation":[{"name":"Department of Pathology, Yamagata University Hospital, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamagata University Hospital, Yamagata, Japan"},{"name":"Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamagata University Hospital, Yamagata, Japan"},{"name":"Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Futakuchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamagata University Hospital, Yamagata, Japan"},{"name":"Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"CIT0003-20250531","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"CIT0004-20250531","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"CIT0006-20250531","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"CIT0007-20250531","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","article-title":"PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers","volume":"29","author":"Gentric","year":"2019","journal-title":"Cell Metab"},{"key":"CIT0008-20250531","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"CIT0009-20250531","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.3802\/jgo.2021.32.e49","article-title":"The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer","volume":"32","author":"Tokunaga","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"CIT0010-20250531","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1530\/ERC-17-0336","article-title":"Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment","volume":"25","author":"van Zyl","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"CIT0011-20250531","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.3390\/molecules23123205","article-title":"Function and interactions of ERCC1-XPF in DNA damage response","volume":"23","author":"Faridounnia","year":"2018","journal-title":"Molecules"},{"key":"CIT0012-20250531","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol Res"},{"key":"CIT0013-20250531","doi-asserted-by":"crossref","first-page":"e146098","DOI":"10.1172\/jci.insight.146098","article-title":"SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer","volume":"6","author":"Winkler","year":"2021","journal-title":"JCI Insight"},{"key":"CIT0014-20250531","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cancers14010004","article-title":"Prognostic significance of SLFN11 methylation in plasma cell-free DNA in advanced high-grade serous ovarian cancer","volume":"14","author":"Tserpeli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"CIT0015-20250531","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3390\/cancers14102353","article-title":"Can Schlafen 11 help to stratify ovarian cancer patients treated with DNA-damaging agents?","volume":"14","author":"Bednarikova","year":"2022","journal-title":"Cancers (Basel)"},{"key":"CIT0016-20250531","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cas.15207","article-title":"Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy","volume":"113","author":"Taniyama","year":"2022","journal-title":"Cancer Sci"},{"key":"CIT0017-20250531","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41416-021-01364-3","article-title":"Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers","volume":"125","author":"Takashima","year":"2021","journal-title":"Br J Cancer"},{"key":"CIT0018-20250531","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1186\/s12885-015-1840-6","article-title":"High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment","volume":"15","author":"Deng","year":"2015","journal-title":"BMC Cancer"},{"key":"CIT0019-20250531","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","article-title":"Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies","volume":"201","author":"Murai","year":"2019","journal-title":"Pharmacol Ther"},{"key":"CIT0020-20250531","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2018.01.012","article-title":"SLFN11 blocks stressed replication forks independently of ATR","volume":"69","author":"Murai","year":"2018","journal-title":"Mol Cell"},{"key":"CIT0021-20250531","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"key":"CIT0022-20250531","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.3390\/ijms231810692","article-title":"Immune tumor microenvironment in ovarian cancer ascites","volume":"23","author":"Almeida-Nunes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"CIT0023-20250531","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/dc.21457","article-title":"Cellient\u2122 automated cell block versus traditional cell block preparation: A comparison of morphologic features and immunohistochemical staining","volume":"39","author":"Wagner","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"CIT0024-20250531","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0970-9371.93210","article-title":"Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology","volume":"29","author":"Shivakumarswamy","year":"2012","journal-title":"J Cytol"},{"key":"CIT0025-20250531","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ajcp\/aqaa028","article-title":"Morphologic and immunocytochemical features of high-grade serous carcinoma of ovary in ascitic fluid effusion and fine-needle aspiration cytology","volume":"154","author":"Bansal","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"CIT0026-20250531","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.2147\/OPTH.S376141","article-title":"Utility of liquid-based cytology and cell block procedure obtained by vitrectomy to diagnose ocular sarcoidosis-the significance of epithelioid granuloma and epithelioid cells","volume":"16","author":"Ohe","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"CIT0027-20250531","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.ejca.2013.04.003","article-title":"Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer","volume":"49","author":"Jakobsen","year":"2013","journal-title":"Eur J Cancer"},{"key":"CIT0028-20250531","first-page":"207","article-title":"Prediction of response to neoadjuvant chemotherapy in Barrett\u2019s carcinoma by quantitative gene expression analysis","volume":"88","author":"Langer","year":"2004","journal-title":"Verh Dtsch Ges Pathol"},{"key":"CIT0029-20250531","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41388-021-01913-3","article-title":"ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"CIT0030-20250531","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/cancers11060838","article-title":"The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance","volume":"11","author":"Loret","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Cytology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joc.joc_152_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:09:37Z","timestamp":1787774977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joc.joc_152_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/joc.joc_152_24","relation":{},"ISSN":["0970-9371","0974-5165"],"issn-type":[{"value":"0970-9371","type":"print"},{"value":"0974-5165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-12-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}